基于贝叶斯线性混合效应模型的个体化萎缩预测家族性额颞叶变性痴呆进展
本研究纳入234例无症状或前驱期C9orf72、GRN或MAPT突变携带者(含21例痴呆转化者),利用贝叶斯线性混合效应模型基于前两次MRI建立个体化灰质轨迹,预测后续加速萎缩簇体积。结果显示该萎缩簇体积可预测痴呆转化,且在24个月内区分转化者的AUC优于其他方法。
要点
- 个体化贝叶斯萎缩评分可预测f-FTLD突变携带者的痴呆转化。
- 在24个月窗口内,BLME簇体积的判别AUC优于其他结构影像方法。
- 该预测方法可能有助于临床 trial 入组和短期随访设计。
核心结论
- 贝叶斯建模的个体化萎缩评分可预测无症状f-FTLD突变携带者的痴呆进展,在较短时间框架内可能优于其他结构影像方法。
研究设计与样本
- 研究纳入234例无症状或前驱期C9orf72、GRN或MAPT突变携带者(含21例痴呆转化者),均有≥3次纵向MRI T1加权扫描。
- 采用贝叶斯线性混合效应模型基于前两次扫描建立个体体素水平灰质轨迹,后续扫描估计加速体积丢失簇。
主要发现
- BLME簇体积总体及分别在C9orf72、GRN和MAPT突变携带者中预测痴呆转化,风险比与萎缩W图和区域体积相当。
- 在24个月时间内,BLME簇体积区分痴呆转化者与非转化者的AUC大于其他方法。
临床怎么用
- 对于无症状f-FTLD突变携带者,可利用纵向MRI个体化萎缩评分辅助预测痴呆转化风险。
- 在临床试验设计较短时间框架时,该个体化萎缩评分可能提高筛选效率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Age of symptom onset is highly variable in familial frontotemporal lobar degeneration (f-FTLD). Accurate prediction of onset would inform clinical management and trial enrollment. Prior studies indicate that individualized maps of brain atrophy can predict conversion to dementia in f-FTLD. We used a Bayesian linear mixed-effect (BLME) prediction method for identifying accelerated brain volume loss to predict conversion to dementia. METHODS: Participants included 234 asymptomatic or prodromal carriers of C9orf72, GRN, or MAPT mutations (including 21 dementia converters) with ≥3 longitudinal magnetic resonance imaging (MRI) T1-weighted scans. The BLME models established individual voxel-wise gray matter trajectories using the first 2 scans. Person-specific clusters of accelerated volume loss were estimated in subsequent scans and tested as predictors of dementia conversion compared with other approaches in time-varying Cox proportional hazard models covarying for age. Receiver-operating characteristic (ROC) curves estimated utility of cluster volume in discriminating which participants converted to dementia within 24 months. RESULTS: The BLME cluster volume predicted conversion to dementia in f-FTLD mutation carriers overall and separately in C9orf72, GRN, and MAPT, with comparable hazard ratios observed for atrophy W-maps and regional volumes. Within a 24-month timeframe, BLME cluster volume discriminated dementia converters from non-converters with larger areas under the curve (AUCs) than other approaches. INTERPRETATION: Bayesian-modeled individualized atrophy scores predict dementia progression among asymptomatic f-FTLD mutation carriers and may have increased utility compared with other structural imaging methods when studying individuals over shorter timeframes that align with clinical trial design. ANN NEUROL 20269999:n/a-n/a.
引用
- Dutt S, Leichter D, Cobigo Y, et al. Individualized Atrophy-Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed-Effects Modeling. Ann Neurol. 2026. PMID: 41608854. doi:10.1002/ana.78167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。